top of page
News
Chat
Insights
Portfolios
Education
About
Pricing
BPIQ API
BPIQ APEX
New Era In Alzheimer's Treatments Brings Opportunities for Biopharma Investors
ALHEIMER’S BREAKTHROUGH
Jun 19, 2023
How does Lecanemab compare to other Alzheimer's assets?
Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...
Jan 4, 2023
How does Lecanemab compare to other Alzheimer's assets?
Summary:
Jan 4, 2023
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page
